Merck & Co. Inc. buy Guggenheim
Start price
11.04.23
/
50%
€103.40
Target price
11.04.24
€113.61
Performance (%)
13.73%
End price
12.04.24
€117.60
Summary
This prediction ended on 12.04.24 with a price of €117.60. The prediction had a final performance of 13.73%. Guggenheim has a follow-up prediction for Merck & Co. Inc. where he still thinks Merck & Co. Inc. is a Buy. Dividends of €2.77 are taken into consideration when calculating the performance. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 8.728% | 8.728% | -8.499% |
| iShares Core DAX® | -0.906% | -3.980% | 19.637% |
| iShares Nasdaq 100 | 0.913% | -0.897% | 8.577% |
| iShares Nikkei 225® | -1.339% | -2.677% | 13.841% |
| iShares S&P 500 | 1.018% | -0.338% | 2.535% |
Comments by Guggenheim for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) had its price target raised by analysts at Guggenheim from $123.00 to $124.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten
Current prediction by Guggenheim for Merck & Co. Inc.
Stopped prediction by Guggenheim for Merck & Co. Inc.
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€94.60
06.11.24
06.11.24
€121.00
06.11.25
06.11.25
-21.04%
07.11.25
07.11.25
